Richard W DeClue
Richard W DeClue publishes mostly in Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Heart Failure Treatment and Management, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.
- World rank
- #7,138,510 of 7,710,434 ranked researchers
- Rank in United States
- #1,586,425 of 1,627,098
- Works
- 32
- Citations
- 166
- Citations per work
- 5.2
What does Richard W DeClue research?
Richard W DeClue's work is mostly in Medicine (50%), Environmental Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1650.0%
- Medicine1650.0%
- Everything else1445.1%
- Physical Sciences24.9%
- 1Oncology13% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Epidemiology6% of their works
- 6Health, Toxicology and Mutagenesis5% of their works
Research topics
Which keywords describe Richard W DeClue's research?
The keywords of their largest research topics: Targeted Therapy, Cardiovascular Disease, Heart Failure, ALK Inhibitors, Diagnosis, EGFR Mutations, Guidelines and Cancer Genomics.
- Immunogenicity
- Chamber Quantification
- Air Pollution
- Mutational Signatures
- Financial Toxicity
- Cancer Genomics
- EGFR Mutations
- ALK Inhibitors
- Cardiovascular Disease
- Targeted Therapy
- Heart Failure
- Diagnosis
- Guidelines
- Cost of Care
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Biosimilars
- Echocardiography
- Particulate Matter
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Targeted Therapy82 topics
- Cardiovascular Disease72 topics
- Heart Failure72 topics
- ALK Inhibitors51 topic
- Diagnosis51 topic
- EGFR Mutations51 topic
- Guidelines51 topic
- Cancer Genomics31 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Immune Checkpoint Blockade31 topic
- Mutational Signatures31 topic
- PD-1 and PD-L131 topic
- Air Pollution21 topic
- Biosimilars21 topic
- Chamber Quantification21 topic
- Echocardiography21 topic
- Immunogenicity21 topic
- Particulate Matter21 topic
Where does Richard W DeClue work?
Richard W DeClue's main affiliation in the publication record is Concert Pharmaceuticals (United States), United States.
How many publications and citations does Richard W DeClue have?
OpenAlex counts 32 works and 166 citations for Richard W DeClue, an h-index of 7, ranking #7,138,510 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Richard W DeClue. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.